Drug Licensing Agreement

Advertisement

cGxPJobs Banner

Nxera and AbbVie Sign $1.47B IBD Drug Licensing Deal

Tokyo, Japan, and Cambridge, United Kingdom, November 4, 2026 Nxera Pharma Co., Ltd. has entered into an exclusive global...

By cGxPwire Editor
November 5, 2026

Read More

Advertisement

cGxPJobs

Directory